Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

被引:0
|
作者
Ran Li
Hongge Liang
Jun Li
Zhenyu Shao
Donghong Yang
Jing Bao
Keqiang Wang
Wen Xi
Zhancheng Gao
Renhua Guo
Xinlin Mu
机构
[1] Peking University People’s Hospital,Department of Respiratory and Critical Care Medicine, Lung Cancer Center
[2] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[3] Qilu Hospital of Shandong University,Department of Radiation Oncology
来源
BMC Cancer | / 24卷
关键词
Paclitaxel liposome; Immunotherapy; Immune checkpoint inhibitor; Non-small cell lung cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Chemotherapy of topotecan combined with paclitaxel in advanced or metastatic non-small cell lung cancer
    Stathopoulos, G. P.
    Katis, C.
    Tsavdaridis, D.
    Dimitroulis, J.
    Karaindros, D.
    Stathopoulos, J.
    Dimou, E.
    EJC SUPPLEMENTS, 2005, 3 (02): : 331 - 331
  • [12] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [13] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [14] Real-World Efficacy and Safety of Anlotinib with and without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Q.
    Qin, B.
    Xin, L.
    Yang, B.
    Hu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S676 - S676
  • [15] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [16] Real-world survival outcomes of immunotherapy for advanced non-small cell lung cancer: A single-center retrospective review
    Punchhi, Gopika
    Hussein, Abdulkadir
    Kulkarni, Swati
    THORACIC CANCER, 2024, 15 (05) : 394 - 401
  • [17] Immunotherapy in Hispanic patients with advanced non-small cell lung cancer: A real-world data.
    Lujan, Mauricio
    Lema, Mauricio
    Preciado, Beatriz
    Lema, Camila
    Egurrola, Jorge
    Zorrilla, Andres Felipe Cardona
    Gonzalez, Diego Mauricio
    Mantilla, William Armando
    Pino, Luis
    Rojas, Gustavo
    Gomez-Abreo, Diego Andres
    Munevar, Isabel
    Manneh, Raimundo
    Kopp, Ray Manneh
    Lobaton, Jose F.
    Calle, Esteban
    Borras, Mariana
    Triana, Ivan Camilo
    Pineda, Mateo
    Ortio, Diego Moran
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [18] Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
    Liu, Si-Yang
    Chen, Qixun
    Zhou, Chengzhi
    Zhang, Huizhong
    Li, Wen
    Chen, Jianhua
    Hu, Jian
    Wu, Lin
    Chen, Qunqing
    Dai, Qiangsheng
    Shan, Jian-Zhen
    Xu, Fei
    Liu, Si-Yang Maggie
    Wu, Yi-Long
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2257 - 2265
  • [19] Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
    Si-Yang Liu
    Qixun Chen
    Chengzhi Zhou
    Huizhong Zhang
    Wen Li
    Jianhua Chen
    Jian Hu
    Lin Wu
    Qunqing Chen
    Qiangsheng Dai
    Jian-Zhen Shan
    Fei Xu
    Si-Yang Maggie Liu
    Yi-Long Wu
    Cancer Immunology, Immunotherapy, 2023, 72 : 2257 - 2265
  • [20] Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study
    Li, Lin
    Li, Wencai
    Wu, Chunyan
    Xi, Yanfeng
    Guo, Lei
    Ji, Yuan
    Jiang, Lili
    Li, Ji
    Yun, Jingping
    Chen, Gang
    Li, Yuan
    Liu, Yueping
    Mu, Dianbin
    Han, Yuchen
    Sun, Leina
    Xia, Qingxin
    Teng, Xiaodong
    Che, Nanying
    Wu, Wei
    Qiu, Xueshan
    Liu, Chao
    Yan, Xiaochu
    Li, Daiqiang
    Zhang, Zhihong
    Wang, Zhe
    Li, Yujun
    Wang, Zheng
    Guo, Lingchuan
    Nie, Xiu
    Geng, Jingshu
    Zhou, Jianhua
    Ying, Jianming
    CANCER COMMUNICATIONS, 2024, 44 (09) : 992 - 1004